Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

New trinem reported by SRI

Sep. 12, 1997

Topical foscarnet for treatment of herpes labialis

Sep. 11, 1997

Excellent penetration of active parent compound in BALF following administration of GS-4104

Sep. 10, 1997

RPR submits NDA for novel antibiotic

Sep. 9, 1997

Kosan receives NIH grant for macrolide antibiotic development

Sep. 9, 1997

Anti-HSV compounds with a novel mechanism of action

Sep. 8, 1997

SmithKline Beecham synthesizes mechanism-based HSV protease inhibitors

Sep. 5, 1997

Leucomycin analogues reported by Meiji Seika

Sep. 3, 1997

Carbohydrate-based antimicrobial agents from Novo Nordisk

Sep. 3, 1997

Novel antimicrobial agents discovered by Ortho

Sep. 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...